What is the current BB Biotech market capitalization?
The current market capitalization of BB Biotech is 2.2 B CHF.
BB Biotech Market capitalization 2024
BB Biotech Market capitalization
2.2 B CHF
Ticker
BION.SW
ISIN
CH0038389992
WKN
A0NFN3
In 2024, BB Biotech's market cap stood at 2.2 B CHF, a 2.76% increase from the 2.14 B CHF market cap in the previous year.
The BB Biotech Market capitalization history
| YEAR | REVENUE (undefined CHF) | GROSS MARGIN (%) | NET INCOME (undefined CHF) |
|---|---|---|---|
| 2025e | 0.1 | -5,14 | 0.19 |
| 2024e | 0.1 | -5,44 | 0.14 |
| 2023 | 0 | -994,72 | -0.21 |
| 2022 | 0 | -36,88 | -0.36 |
| 2021 | -0.34 | 100,29 | -0.4 |
| 2020 | 0.74 | 99,88 | 0.69 |
| 2019 | 0.73 | 99,83 | 0.68 |
| 2018 | 0.01 | 81,20 | -0.47 |
| 2017 | 0.73 | 99,93 | 0.69 |
| 2016 | 0.01 | 88,57 | -0.8 |
| 2015 | 0.7 | 99,97 | 0.65 |
| 2014 | 1.5 | 99,96 | 1.47 |
| 2013 | 0.95 | 99,89 | 0.93 |
| 2012 | 0.39 | 99,31 | 0.37 |
| 2011 | -0.05 | 112,94 | -0.07 |
| 2010 | -0.13 | 104,68 | -0.15 |
| 2009 | 0.05 | 89,45 | 0.04 |
| 2008 | 0.07 | 84,55 | 0.05 |
| 2007 | -0.21 | 106,45 | -0.27 |
| 2006 | 0.32 | 98,49 | 0.3 |
| 2005 | 0.33 | 99,97 | 0.32 |
| 2004 | 0.21 | 100,00 | 0.2 |
BB Biotech Aktienanalyse
What does BB Biotech do?
BB Biotech AG is a Swiss investment company specializing in biotechnology and life sciences. The company was founded in 1993 and has been listed on the SIX Swiss Exchange since 1995. BB Biotech AG primarily invests in publicly traded companies in Europe and North America that are active in the biotechnology and healthcare industry. The business model of BB Biotech AG is based on a combination of active portfolio management and long-term investment strategy. The company invests in stocks of biotechnology and healthcare companies that typically do not yet generate profits but are developing promising products or technologies. BB Biotech AG focuses on high portfolio diversification to minimize risk. BB Biotech AG is divided into three business areas: biotechnology, pharmaceuticals, and medtech. The emphasis is on biotechnology, where the company invests in stocks of well-known biotech companies such as Celgene, Gilead Sciences, Regeneron, and Biogen. In the pharmaceutical sector, BB Biotech AG invests in large pharmaceutical companies like Roche, Novartis, or Pfizer. In the medtech sector, the company invests in companies specializing in the development of medical devices and instruments, such as Intuitive Surgical or Neurocrine Biosciences. BB Biotech AG provides added value to its investors through continuous monitoring of the companies in the portfolio and risk management. The company ensures that investors are always informed about the latest developments in the biotechnology and healthcare industry and regularly publishes reports about the portfolio. The portfolio of BB Biotech AG consists of over 30 different biotech, pharmaceutical, and medtech companies. The main holdings of BB Biotech AG are Celgene, Gilead Sciences, Biogen, Incyte, Vertex Pharmaceuticals, Regeneron, and Neurocrine Biosciences. Celgene is one of the world's leading biotech companies specializing in the development of drugs against cancer and other serious diseases. Gilead Sciences is a biotech company specializing in the research of new therapies for the treatment of infectious diseases such as HIV and hepatitis. Biogen is a biotech company specializing in the treatment of neurological disorders such as multiple sclerosis. Incyte is a biotech company specializing in the development of drugs against cancer and inflammatory diseases. Vertex Pharmaceuticals is a biotech company specializing in the treatment of cystic fibrosis. Regeneron is a biotech company specializing in the development of drugs against eye diseases such as macular degeneration and other serious diseases. Neurocrine Biosciences is a medtech company specializing in the development of drugs against sleep disorders and other neurological diseases. BB Biotech AG is an important player in the market for biotechnology and healthcare investments. Through smart selection of investment targets and systematic risk monitoring, the company has enabled investors to achieve high returns with comparatively low risk. Due to these factors, it is now one of the most important holdings in the biotechnology and healthcare sector. BB Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring BB Biotech's Market Capitalization
BB Biotech's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of BB Biotech's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
BB Biotech's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in BB Biotech’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about BB Biotech Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like BB Biotech.
How has the market capitalization of BB Biotech developed in recent years?
The market capitalization of BB Biotech has increased/decreased by 2.76% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of BB Biotech?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of BB Biotech?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of BB Biotech have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does BB Biotech pay?
Over the past 12 months, BB Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BB Biotech is expected to pay a dividend of 0 CHF.
What is the dividend yield of BB Biotech?
The current dividend yield of BB Biotech is .
When does BB Biotech pay dividends?
BB Biotech pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BB Biotech?
BB Biotech paid dividends every year for the past 0 years.
What is the dividend of BB Biotech?
For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.
In which sector is BB Biotech located?
BB Biotech is assigned to the '-' sector.
Wann musste ich die Aktien von BB Biotech kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BB Biotech from 6/13/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.
When did BB Biotech pay the last dividend?
The last dividend was paid out on 6/13/2024.
What was the dividend of BB Biotech in the year 2023?
In the year 2023, BB Biotech distributed 0 CHF as dividends.
In which currency does BB Biotech pay out the dividend?
The dividends of BB Biotech are distributed in CHF.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The BB Biotech stock can be added to a savings plan with the following providers: ING
Andere Kennzahlen von BB Biotech
Our stock analysis for BB Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BB Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.